Resveratrol: Clinical Evidence & Substantiation Summary
What Is Resveratrol?
Resveratrol is a polyphenol found in red grape skins, red wine, and Japanese knotweed. It activates sirtuins and AMPK, with clinical evidence supporting cardiovascular protection, anti-inflammatory effects, and metabolic health.
Mechanism of action: Resveratrol activates SIRT1 (a NAD+-dependent deacetylase involved in longevity pathways), AMPK, and Nrf2 antioxidant pathways. It inhibits NF-κB-mediated inflammation and improves endothelial function via eNOS upregulation and nitric oxide production.
Clinical Evidence Summary
Below are 3 key clinical studies on Resveratrol. Nutra Comp analyses 41+ studies in its full clinical evidence report.
Resveratrol and cardiovascular health: a meta-analysis
Population: 19 RCTs, 1,112 participants
Key finding: Resveratrol significantly improved flow-mediated dilation (FMD: +1.46%, p=0.002) and reduced systolic blood pressure (WMD: -2.1 mmHg).
Resveratrol supplementation and inflammatory markers
Population: 15 RCTs
Key finding: Resveratrol significantly reduced CRP (WMD: -0.54 mg/L, p=0.01) and TNF-α in overweight and diabetic populations.
Resveratrol and glycaemic control in type 2 diabetes
Population: 11 RCTs
Key finding: Resveratrol supplementation improved fasting glucose (WMD: -9.8 mg/dL, p=0.003) and insulin sensitivity (HOMA-IR: -0.52, p=0.01).
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for Resveratrol
Includes all 41+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is resveratrol FDA approved?
Resveratrol is a dietary supplement under DSHEA. It does not require FDA approval. Trans-resveratrol has self-affirmed GRAS status.
What are the most studied benefits?
The strongest evidence supports resveratrol for cardiovascular health (improved blood flow, blood pressure), anti-inflammatory effects, and metabolic health in diabetic populations.
What dosage is used in clinical studies?
Most studies use 150–500 mg/day of trans-resveratrol. Bioavailability is low; micronised and phytosome forms may improve absorption.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist